More on NRSN

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (6.7 Score)

Upcoming Events

- Earnings (12/2/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Neurosense Therapeutics (NQ:NRSN)
Delayed: 3.07 -0.1 (3.15%)
Prev. Close $3.17  
Open$3.06 
52 Wk High$ 
52 Wk Low$ 
Day High$3.24 
Day Low$3.06 
P/E N/A  
EPS$ 
Volume9,705 

Friends, Peers and Foes (?): NRSNW H1Z (more...)

Oct 13, 2026 08:41 AM Form 6-K NeuroSense Therapeutics For: Oct 13
Oct 13, 2026 08:31 AM NeuroSense schedules Nasdaq hearing for November amid listing issues
Oct 13, 2026 08:30 AM NeuroSense Secures Nasdaq Hearing Date as PrimeC Approaches Key Regulatory and Funding Milestones
Oct 12, 2026 04:37 PM Roth/MKM Downgrades NeuroSense Therapeutics Ltd. (NRSN) to Neutral
Oct 2, 2026 04:20 PM NeuroSense faces Nasdaq delisting risk over market value rule
Oct 2, 2026 04:15 PM Form 6-K NeuroSense Therapeutics For: Oct 02
Oct 2, 2026 04:15 PM NeuroSense Provides Update on Nasdaq Listing Compliance
Sep 28, 2026 12:43 PM NeuroSense to Participate in the 5th Annual ROTH Healthcare Opportunities Conference
Sep 28, 2026 06:56 AM NeuroSense Therapeutics Ltd. (NRSN) PT Raised to $52 at H.C. Wainwright
Sep 25, 2026 04:31 PM Form 6-K NeuroSense Therapeutics For: Jun 30
View All Articles

Entities mentioned with NRSN

View All Entities